Table 4.
Therapies employed in patients with PCH
| Therapy | Patients (n = 229)∗ |
|---|---|
| None | 72 |
| Steroids | 57 |
| Antimicrobials | 13 |
| Steroids, antimicrobials | 8 |
| Steroids, IVIG | 5 |
| Steroids, rituximab | 4 |
| Steroids, CHOP | 3 |
| Steroids, azathioprine | 2 |
| Steroids, chlorambucil | 2 |
| Antimicrobials, IVIG | 1 |
| Rituximab | 1 |
| Rituximab, fludarabine, cyclophosphamide, danazol | 1 |
| Steroids, androgen therapy | 1 |
| Steroids, antimicrobials, IVIG | 1 |
| Steroids, azathioprine, rituximab | 1 |
| Steroids, cyclophosphamide, rituximab | 1 |
| Steroids, danazol | 1 |
| Steroids, eculizumab, antimicrobials | 1 |
| Steroids, eculizumab, antimicrobials, TPE | 1 |
| Steroids, eculizumab, cyclophosphamide | 1 |
| Steroids, IVIG, antimicrobials | 1 |
| Steroids, IVIG, rituximab | 1 |
| Steroids, IVIG, TPE | 1 |
| Steroids, rituximab, cyclophosphamide | 1 |
| Steroids, TPE | 1 |
| TPE | 1 |
CHOP, cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone; IVIG, intravenous immunoglobulin; TPE, therapeutic plasma exchange.
∗
Therapy was not reported for 47 patients.